Antiheparin Activity of Human Serum and Platelet Factor 4

Summary

The antiheparin activity of normal serum has been studied by comparing the antiheparin activities of sera obtained from normal whole blood, platelet-rich plasma and platelet-’free’ plasma with a purified platelet extract during differential isoelectric precipitation and by gel filtration chromatography.

The mean values for the activity of PRP-serum and PFP-serum were 106% (S.D. 11) and 10% (S.D. 3) of untreated whole blood respectively. The activity of whole blood serum, PRP serum and whole blood serum plus platelet extract precipitated under identical physical conditions, i.e. pH 7.0, I =0.008, indicating that the activities of the three samples are probably associated with PF4. PF4 precipitated from human platelet extract at pH 4.0, but this is probably due to the difference in the two biochemical environments investigated, i.e. serum and platelet extract.

The gel filtration experiments revealed striking similarities between the major antiheparin activities of serum and platelet extract. At physiological pH and ionic strength both activities were associated with high molecular weight material, but at physiological pH and elevated ionic strength both activities behaved as much smaller entities of molecular weight between 25,000 and 30,000 daltons and it seems very likely that both activities are associated with the same molecule, i.e. PF4.

^* Requests for reprints to LP

• References

• 1 Barber A. J, Kaser-Glazmann R, and Luscher E. F. 1973 Characterisation of the carbohydrate moiety of a proteoglycan-protein complex with heparin neutralising activity (platelet factor 4) released from human blood platelets. (in press).
• 2 Brecher G, and Cronkite E. P. 1950; Morphology and enumeration of human blood platelets. Journal of Applied Physiology 3: 365.
• 3 Curling J. M. 1970; The use of Sephadex in the separation, purification and characterisation of biological materials. Experiments in Physiology and Biochemistry 3: 417.
• 4 Dewhurst F, and Poller L. 1965; Antiheparin activity of some human blood protein fractions and their possible relationship to thrombosis. Journal of Clinical Pathology 18: 339.
• 5 Farbiszewski R, Niewiarowski S, and Poplawski A. 1966; Purification and separation of platelet factor 2 (fibrinogen activating factor) and of platelet factor 4 (antiheparin factor). Biochimica et Biophysica Acta 115: 397.
• 6 Farbiszewski R, Lipinski B, Niewiarowski S, and Polawski A. 1968; Hypercoagulability and thrombocytopenia after platelet factor 4 infusion into rabbits. Experientia 24: 578.
• 7 Harada K, and Zucker M. B. 1971; Simultaneous development of platelet factor 4 activity and release of ¹⁴C-serotonin. Thrombosis et Diathesis Haemorrhagica 35: 41.
• 8 Hartmann R. C. 1961. Platelets and heparin. In: Johnson S. A, Monto R. W, Rebuck J.W, and Horn R. C. (eds.) Blood platelets. Henry Ford Hospital International Symposium. Little Brown and Co.; Boston: 499.
• 9 Hermansky F, and Matousova O. 1968; Antiheparin activity of serum. Casopis Lekaru Ceskych 107: 515.
• 10 Holger-Madsen T. 1962; Studies on the antiheparin activity of serum. Thrombosis et Diathesis Haemorrhagica 7: 188.
• 11 Lopaciuk S, and Solum N. O. 1969; Bovine platelet proteins. 1. Soluble proteins studied by Immunoelectrophoresis and Polyacrylamide disc electrophoresis. Thrombosis et Diathesis Haemorrhagica 21: 409.
• 12 Lowry O. H, Rosebrough N. J, Farr A. L, and Randall R. J. 1951; Protein measurements with the Folin phenol reagent. Journal of Biological Chemistry 193: 265.
• 13 Luscher E. F. 1959. Die Biochemie der Gerinnungsfaktoren der Thrombozyten. In: Deutsch E. (Ed.) Blood Clotting Factors. Proceedings of the 4th International Congress of Biochemistry. Pergamon Press; N.Y.: 75.
• 14 Moriau M. 1969; Have the platelet antiheparin and antiplasmin activities the same support?. Thrombosis et Diathesis Haemorrhagica 22: 403.
• 15 Niewiarowski S, Zywicka H, and Latallo Z. 1962; Coagulation disorders in thrombocy-thaemia, a study of seven cases. Thrombosis et Diatheses Haemorrhagica 7: 114.
• 16 Niewiarowski S, Farbiszewski R, and Poplawski A. 1967. Studies on platelet factor 2 (PF2-fibrinogen activating factor) and platelet factor 4 (PF4-antiheparin activity). In: Kowalski E, and Niewiarowski S. (Eds.) Biochemistry of Blood Platelets. Academic Press; London and New York.: 35.
• 17 Niewiarowski S, Poplawski A, Lipinski B, and Farbiszewski R. 1968; The release of Platelet clotting factors during aggregation and viscous metamorphosis. Experiments in Biology and Medicine 3: 121.
• 18 Niewiarowski S, and Thomas D. P. 1969; Platelet factor 4 and adenosine diphosphate release during human platelet aggregation. Nature 222: 1269.
• 19 Pepper D. S, and Moore S. 1972 Isolation, characterisation and assay of platelet factor 4 (antiheparin). Personal communication.
• 20 Pitlick F. A, Lundblad R. L, and Davie E. W. 1969; The role of heparin in intrinsic blood coagulation. Journal of Biomedical Materials Research 3: 95.
• 21 Poller L. 1960; The possible relationship between the antiheparin activity of serum and thrombosis. Journal of Clinical Pathology 13: 226.
• 22 Poplawski A, and Niewiarowski S. 1965; Method for determining antiheparin activity of platelets and erythrocytes. Thrombosis et Diathese Haemorrhagica 13: 149.
• 23 Soulier J. P, and LeBolloch A. G. 1950; Le test de tolerance a l’heparine “in vitro”. Revue d’Hématologie 5: 148.
• 24 Thomas D. P, Niewiarowski S, and Ream V. J. 1971; Release of adenine nucleotides and platelet factor 4 from platelets of man and four other species. Journal of Laboratory and Clinical Medicine 75: 607.
• 25 Triantaphyllopoulos D.C. 1956; Blood globulins reducing the anticoagulant activity of heparin. Canadian Journal of Biochemistry and Physiology 34: 939.